{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:53:08Z","timestamp":1792601588472,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T00:00:00Z","timestamp":1412640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T00:00:00Z","timestamp":1412640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Biomarkers to identify osteoarthritis (OA) patients at risk for disease progression are needed. As part of a proteomic analysis of knee synovial fluid from normal and OA patients, differentially expressed proteins were identified that could represent potential biomarkers for OA. This study aimed to use mass spectrometry assays to identify representative peptides from several proteins in synovial fluid and peripheral blood, and assess their levels as biomarkers of OA progression.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Multiplexed high throughput selected reaction monitoring (SRM) assays were developed to measure tryptic peptides representative of 23 proteins in matched serum and synovial fluid samples from late OA subjects at the time of joint replacement. Subsequently plasma samples from the baseline visit of 173 subjects in an observational OA cohort were tested by SRM for peptides from nine of these proteins: afamin, clusterin, cartilage oligomeric matrix protein, hepatocyte growth factor, kallistatin, insulin-like growth factor binding protein, acid labile subunit, lubricin, lumican, and pigment epithelium-derived factor. Linear regression was used to determine the association between the peptide biomarker level at baseline and change in joint space width (\u0394JSW) from baseline to 30 months, adjusting for age and sex.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>In the matched cohort, 17 proteins could be identified in synovial fluid and 16 proteins were detected in serum. For the progression cohort, the average age was 62 and average \u0394JSW over 30 months was 0.68 mm. A high correlation between different peptides from individual proteins was observed, indicating our assays correctly measured their target proteins. Peptides representative of clusterin, lumican and lubricin showed statistically significant associations with joint space narrowing after adjustment for age and sex. Partial R<jats:sup>2<\/jats:sup> values showed clusterin FMETVAEK and lubricin LVEVNPK peptide biomarkers explains about 2 to 3% of the variability of \u0394JSW, similar to that explained by age. A biomarker score combining normalized data for both lubricin and clusterin peptides increased the model R<jats:sup>2<\/jats:sup> to 0.079.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Our results suggest that when combined, levels of peptides representative of clusterin and lubricin in plasma are as predictive of OA progression as age. Replication of these findings in other prospective OA cohorts is planned.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13075-014-0456-6","type":"journal-article","created":{"date-parts":[[2014,10,6]],"date-time":"2014-10-06T11:06:24Z","timestamp":1412593584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Mass spectrometry assays of plasma biomarkers to predict radiographic progression of knee osteoarthritis"],"prefix":"10.1186","volume":"16","author":[{"given":"Susan Y","family":"Ritter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Krastins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sarracino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Losina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios O","family":"Aliprantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,7]]},"reference":[{"key":"456_CR1","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1002\/art.24984","volume":"60","author":"H Kotlarz","year":"2009","unstructured":"Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA: Insurer and out-of-pocket costs of osteoarthritis in the US: Evidence from national survey data. Arthritis Rheum. 2009, 60: 3546-3553. 10.1002\/art.24984.","journal-title":"Arthritis Rheum"},{"key":"456_CR2","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.joca.2012.07.009","volume":"20","author":"A Mobasheri","year":"2012","unstructured":"Mobasheri A: Osteoarthritis year 2012 in review: biomarkers. Osteoarthritis Cartilage. 2012, 20: 1451-1464. 10.1016\/j.joca.2012.07.009.","journal-title":"Osteoarthritis Cartilage"},{"key":"456_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jim.2009.06.003","volume":"347","author":"AN Hoofnagle","year":"2009","unstructured":"Hoofnagle AN, Wener MH: The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J Immunol Methods. 2009, 347: 3-11. 10.1016\/j.jim.2009.06.003.","journal-title":"J Immunol Methods"},{"key":"456_CR4","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1373\/clinchem.2010.152264","volume":"56","author":"SA Agger","year":"2010","unstructured":"Agger SA, Marney LC, Hoofnagle AN: Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple- reaction-monitoring mass spectrometry. Clin Chem. 2010, 56: 1804-1813. 10.1373\/clinchem.2010.152264.","journal-title":"Clin Chem"},{"key":"456_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/prca.200900217","volume":"4","author":"Q Fu","year":"2010","unstructured":"Fu Q, Schoenhoff FS, Savage WJ, Zhang P, Van Eyk JE: Multiplex assays for biomarker research and clinical application: translational science coming of age. Proteomics Clin Appl. 2010, 4: 271-284. 10.1002\/prca.200900217.","journal-title":"Proteomics Clin Appl"},{"key":"456_CR6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nbt.1546","volume":"27","author":"TA Addona","year":"2009","unstructured":"Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, Spiegelman CH, Zimmerman LJ, Ham AJ, Keshishian H, Hall SC, Allen S, Blackman RK, Borchers CH, Buck C, Cardasis HL, Cusack MP, Dodder NG, Gibson BW, Held JM, Hiltke T, Jackson A, Johansen EB, Kinsinger CR, Li J, Mesri M, Neubert TA, Niles RK, Pulsipher TC, Ransohoff D: Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol. 2009, 27: 633-641. 10.1038\/nbt.1546.","journal-title":"Nat Biotechnol"},{"key":"456_CR7","doi-asserted-by":"publisher","first-page":"6678","DOI":"10.1021\/pr100821m","volume":"9","author":"A Prakash","year":"2010","unstructured":"Prakash A, Rezai T, Krastins B, Sarracino D, Athanas M, Russo P, Ross MM, Zhang H, Tian Y, Kulasingam V, Crabovich AP, Smith C, Batruch I, Liotta L, Petricoin E, Diamandis EP, Chand DW, Lopez MF: Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays. J Proteome Res. 2010, 9: 6678-6688. 10.1021\/pr100821m.","journal-title":"J Proteome Res"},{"key":"456_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/art.37823","volume":"65","author":"SY Ritter","year":"2013","unstructured":"Ritter SY, Subbaiah R, Bebek G, Crish J, Scanzello CR, Krastins B, Sarracino D, Lopez MF, Crow MK, Aigner T, Goldring MB, Goldring SR, Lee DM, Gobezie R, Aliprantis AO: Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues. Arthritis Rheum. 2013, 65: 981-992. 10.1002\/art.37823.","journal-title":"Arthritis Rheum"},{"key":"456_CR9","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/ar2172","volume":"9","author":"R Gobezie","year":"2007","unstructured":"Gobezie R, Kho A, Krastins B, Sarracino DA, Thornhill TS, Chase M, Millett PJ, Lee DM: High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther. 2007, 9: R36-10.1186\/ar2172.","journal-title":"Arthritis Res Ther"},{"key":"456_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1136\/ard.2005.039115","volume":"65","author":"SA Mazzuca","year":"2006","unstructured":"Mazzuca SA, Brandt KD, Katz BP, Ding Y, Lane KA, Buckwalter KA: Risk factors for progression of tibiofemoral osteoarthritis: an analysis based on fluoroscopically standardised knee radiography. Ann Rheum Dis. 2006, 65: 515-519. 10.1136\/ard.2005.039115.","journal-title":"Ann Rheum Dis"},{"key":"456_CR11","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/pmic.201000511","volume":"11","author":"J Campbell","year":"2011","unstructured":"Campbell J, Rezai T, Prakash A, Krastins B, Dayon L, Ward M, Robinson S, Lopez M: Evaluation of absolute peptide quantitation strategies using selected reaction monitoring. Proteomics. 2011, 11: 1148-1152. 10.1002\/pmic.201000511.","journal-title":"Proteomics"},{"key":"456_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1021\/pr100153j","volume":"10","author":"MF Lopez","year":"2011","unstructured":"Lopez MF, Kuppusamy R, Sarracino DA, Prakash A, Athanas M, Krastins B, Rezai T, Sutton JN, Peterman S, Nicolaides K: Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum. J Proteome Res. 2011, 10: 133-142. 10.1021\/pr100153j.","journal-title":"J Proteome Res"},{"key":"456_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/prca.201100041","volume":"6","author":"MF Lopez","year":"2012","unstructured":"Lopez MF, Sarracino DA, Prakash A, Athanas M, Krastins B, Rezai T, Sutton JN, Peterman S, Gvozdyak O, Chou S, Lo E, Buonanno F, Ning M: Discrimination of ischemic and hemorrhagic strokes using a multiplexed, mass spec-based assay for serum apolipoproteins coupled to multi-marker ROC algorithm. Proteomics Clin Appl. 2012, 6: 190-200. 10.1002\/prca.201100041.","journal-title":"Proteomics Clin Appl"},{"key":"456_CR14","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1002\/art.27577","volume":"62","author":"CP Neu","year":"2010","unstructured":"Neu CP, Reddi AH, Komvopoulos K, Schmid TM, Di Cesare PE: Increased friction coefficient and superficial zone protein expression in patients with advanced osteoarthritis. Arthritis Rheum. 2010, 62: 2680-2687. 10.1002\/art.27577.","journal-title":"Arthritis Rheum"},{"key":"456_CR15","doi-asserted-by":"crossref","unstructured":"Ruan MZ, Erez A, Guse K, Dawson B, Bertin T, Chen Y, Jiang MM, Yustein J, Gannon F, Lee BH: Proteoglycan 4 expression protects against the development of osteoarthritis.Sci Transl Med 2013, 5:176ra134.,","DOI":"10.1126\/scitranslmed.3005409"},{"key":"456_CR16","doi-asserted-by":"publisher","first-page":"5852","DOI":"10.1073\/pnas.1219289110","volume":"110","author":"KA Waller","year":"2013","unstructured":"Waller KA, Zhang LX, Elsaid KA, Fleming BC, Warman ML, Jay GD: Role of lubricin and boundary lubrication in the prevention of chondrocyte apoptosis. Proc Natl Acad Sci USA. 2013, 110: 5852-5857. 10.1073\/pnas.1219289110.","journal-title":"Proc Natl Acad Sci USA"},{"key":"456_CR17","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1053\/joca.2001.0475","volume":"9","author":"JR Connor","year":"2001","unstructured":"Connor JR, Kumar S, Sathe G, Mooney J, O'Brien SP, Mui P, Murdock PR, Gowen M, Lark MW: Clusterin expression in adult human normal and osteoarthritic articular cartilage. Osteoarthritis Cartilage. 2001, 9: 727-737. 10.1053\/joca.2001.0475.","journal-title":"Osteoarthritis Cartilage"},{"key":"456_CR18","first-page":"745","volume":"25","author":"E Fandridis","year":"2011","unstructured":"Fandridis E, Apergis G, Korres DS, Nikolopoulos K, Zoubos AB, Papassideri I, Trougakos IP: Increased expression levels of apolipoprotein J\/clusterin during primary osteoarthritis. In Vivo. 2011, 25: 745-749.","journal-title":"In Vivo"},{"key":"456_CR19","doi-asserted-by":"publisher","first-page":"6471","DOI":"10.4049\/jimmunol.177.9.6471","volume":"177","author":"V Devauchelle","year":"2006","unstructured":"Devauchelle V, Essabbani A, De Pinieux G, Germain S, Tourneur L, Mistou S, Margottin-Goguet F, Anract P, Migaud H, Le Nen D, Lequerre T, Saraux A, Dougados M, Breban M, Rournier C, Chiocchia G: Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritis. J Immunol. 2006, 177: 6471-6479. 10.4049\/jimmunol.177.9.6471.","journal-title":"J Immunol"},{"key":"456_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2249.1994.tb06256.x","volume":"97","author":"J Tschopp","year":"1994","unstructured":"Tschopp J, French LE: Clusterin: modulation of complement function. Clin Exp Immunol. 1994, 97: 11-14. 10.1111\/j.1365-2249.1994.tb06256.x.","journal-title":"Clin Exp Immunol"},{"key":"456_CR21","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1038\/nm.2543","volume":"17","author":"Q Wang","year":"2011","unstructured":"Wang Q, Rozelle AL, Lepus CM, Scanzello CR, Song JJ, Larsen DM, Crish JF, Bebek G, Ritter SY, Lindstrom TM, Hwang I, Wong HH, Punzi L, Encarnacion A, Shamloo M, Goodman SB, Wyss-Coray T, Goldring SR, Banda NK, Thurman JM, Gobezie R, Crow MK, Holers VM, Lee DM, Robinson WH: Identification of a central role for complement in osteoarthritis. Nat Med. 2011, 17: 1674-1679. 10.1038\/nm.2543.","journal-title":"Nat Med"},{"key":"456_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1523-1755.2001.00474.x","volume":"59","author":"K Yamada","year":"2001","unstructured":"Yamada K, Hori Y, Hanafusa N, Okuda T, Nagano N, Choi-Miura NH, Couser WG, Miyata T, Kurokawa K, Fujita T, Nangaku M: Clusterin is up-regulated in glomerular mesangial cells in complement-mediated injury. Kidney Int. 2001, 59: 137-146. 10.1046\/j.1523-1755.2001.00474.x.","journal-title":"Kidney Int"},{"key":"456_CR23","first-page":"594","volume":"27","author":"GD Jay","year":"2000","unstructured":"Jay GD, Britt DE, Cha CJ: Lubricin is a product of megakaryocyte stimulating factor gene expression by human synovial fibroblasts. J Rheumatol. 2000, 27: 594-600.","journal-title":"J Rheumatol"},{"key":"456_CR24","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1172\/JCI200522263","volume":"115","author":"DK Rhee","year":"2005","unstructured":"Rhee DK, Marcelino J, Baker M, Gong Y, Smits P, Lefebvre V, Jay GD, Stewart M, Wang H, Warman ML, Carpten JD: The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J Clin Invest. 2005, 115: 622-631. 10.1172\/JCI200522263.","journal-title":"J Clin Invest"},{"key":"456_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/03009748909101468","volume":"18","author":"KD Brandt","year":"1989","unstructured":"Brandt KD: A pessimistic view of serologic markers for diagnosis and management of osteoarthritis. Biochemical, immunologic and clinicopathologic barriers. J Rheumatol Suppl. 1989, 18: 39-42. 10.3109\/03009748909101468.","journal-title":"J Rheumatol Suppl"},{"key":"456_CR26","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.joca.2008.07.009","volume":"17","author":"EB Dam","year":"2009","unstructured":"Dam EB, Byrjalsen I, Karsdal MA, Qvist P, Christiansen C: Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI. Osteoarthritis Cartilage. 2009, 17: 384-389. 10.1016\/j.joca.2008.07.009.","journal-title":"Osteoarthritis Cartilage"},{"key":"456_CR27","doi-asserted-by":"publisher","first-page":"e9739","DOI":"10.1371\/journal.pone.0009739","volume":"5","author":"VB Kraus","year":"2010","unstructured":"Kraus VB, Kepler TB, Stabler T, Renner J, Jordan J: First qualification study of serum biomarkers as indicators of total body burden of osteoarthritis. PLoS One. 2010, 5: e9739-10.1371\/journal.pone.0009739.","journal-title":"PLoS One"},{"key":"456_CR28","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1002\/art.30412","volume":"63","author":"YM Golightly","year":"2011","unstructured":"Golightly YM, Marshall SW, Kraus VB, Renner JB, Villaveces A, Casteel C, Jordan JM: Biomarkers of incident radiographic knee osteoarthritis: Do they vary by chronic knee symptoms?. Arthritis Rheum. 2011, 63: 2276-2283. 10.1002\/art.30412.","journal-title":"Arthritis Rheum"},{"key":"456_CR29","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/art.34315","volume":"64","author":"PL van Lent","year":"2012","unstructured":"van Lent PL, Blom AB, Schelbergen RF, Sloetjes A, Lafeber FP, Lems WF, Cats H, Vogl T, Roth J, van den Berg WB: Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. Arthritis Rheum. 2012, 64: 1466-1476. 10.1002\/art.34315.","journal-title":"Arthritis Rheum"},{"key":"456_CR30","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.joca.2012.05.002","volume":"20","author":"TN de Boer","year":"2012","unstructured":"de Boer TN, van Spil WE, Huisman AM, Polak AA, Bijlsma JW, Lafeber FP, Mastbergen SC: Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage. Osteoarthritis Cartilage. 2012, 20: 846-853. 10.1016\/j.joca.2012.05.002.","journal-title":"Osteoarthritis Cartilage"},{"key":"456_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.joca.2013.12.004","volume":"22","author":"HG Wisniewski","year":"2014","unstructured":"Wisniewski HG, Colon E, Liublinska V, Karia RJ, Stabler TV, Attur M, Abramson SB, Band PA, Kraus VB: TSG-6 activity as a novel biomarker of progression in knee osteoarthritis. Osteoarthritis Cartilage. 2014, 22: 235-241. 10.1016\/j.joca.2013.12.004.","journal-title":"Osteoarthritis Cartilage"},{"key":"456_CR32","doi-asserted-by":"publisher","first-page":"R22","DOI":"10.1186\/ar3246","volume":"13","author":"M Ishijima","year":"2011","unstructured":"Ishijima M, Watari T, Naito K, Kaneko H, Futami I, Yoshimura-Ishida K, Tomonaga A, Yamaguchi H, Yamamoto T, Nagaoka I, Kurosawa H, Poole RA, Kaneko K: Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis. Arthritis Res Ther. 2011, 13: R22-10.1186\/ar3246.","journal-title":"Arthritis Res Ther"},{"key":"456_CR33","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.joca.2012.04.004","volume":"20","author":"WE van Spil","year":"2012","unstructured":"van Spil WE, Jansen NW, Bijlsma JW, Reijman M, DeGroot J, Welsing PM, Lafeber FP: Clusters within a wide spectrum of biochemical markers for osteoarthritis: data from CHECK, a large cohort of individuals with very early symptomatic osteoarthritis. Osteoarthritis Cartilage. 2012, 20: 745-754. 10.1016\/j.joca.2012.04.004.","journal-title":"Osteoarthritis Cartilage"},{"key":"456_CR34","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.clinbiochem.2012.12.019","volume":"46","author":"B Krastins","year":"2013","unstructured":"Krastins B, Prakash A, Sarracino DA, Nedelkov D, Niederkofler EE, Kiernan UA, Nelson R, Vogelsang MS, Vadali G, Garces A, Sutton JN, Peterman S, Byram G, Darbouret B, Perusse JR, Seidah NG, Coulombe B, Gobom J, Portlius E, Panne J, Blennow K, Kulaqsingam V, Couchman L, Moniz C, Lopez MF: Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum. Clin Biochem. 2013, 46: 399-410. 10.1016\/j.clinbiochem.2012.12.019.","journal-title":"Clin Biochem"},{"key":"456_CR35","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1373\/clinchem.2011.173856","volume":"58","author":"AN Hoofnagle","year":"2012","unstructured":"Hoofnagle AN, Becker JO, Oda MN, Cavigiolio G, Mayer P, Vaisar T: Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures. Clin Chem. 2012, 58: 777-781. 10.1373\/clinchem.2011.173856.","journal-title":"Clin Chem"},{"key":"456_CR36","doi-asserted-by":"publisher","first-page":"D655","DOI":"10.1093\/nar\/gkj040","volume":"34","author":"F Desiere","year":"2006","unstructured":"Desiere F, Deutsch EW, King NL, Nesvizhskii AI, Mallick P, Eng J, Chen S, Eddes J, Loevenich SN, Aebersold R: The PeptideAtlas project. Nucleic Acids Res. 2006, 34: D655-D658. 10.1093\/nar\/gkj040.","journal-title":"Nucleic Acids Res"},{"key":"456_CR37","doi-asserted-by":"publisher","first-page":"e43457","DOI":"10.1371\/journal.pone.0043457","volume":"7","author":"C Bystrom","year":"2012","unstructured":"Bystrom C, Sheng S, Zhang K, Caulfield M, Clarke NJ, Reitz R: Clinical utility of insulin-like growth factor 1 and 2; determination by high resolution mass spectrometry. PLoS One. 2012, 7: e43457-10.1371\/journal.pone.0043457.","journal-title":"PLoS One"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0456-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-014-0456-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0456-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0456-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:23:44Z","timestamp":1728923024000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-014-0456-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,7]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,10]]}},"alternative-id":["456"],"URL":"https:\/\/doi.org\/10.1186\/s13075-014-0456-6","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,7]]},"assertion":[{"value":"22 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"456"}}